Variable description | Model 1 | Model 2 | Model 3 | Model 4 | Model 5 |
---|---|---|---|---|---|
N | 184 | 183 | 182 | 182 | 182 |
Employed at survey | Yes | Yes | Yes | Yes | Yes |
Constant | 0.333*** | 0.701*** | 0.812** | 0.955*** | 0.962*** |
(3.85) | (3.70) | (3.20) | (3.79) | (3.71) | |
Employed before HDT-ASCT | 0.448*** | 0.445*** | 0.436*** | 0.384*** | 0.373*** |
(4.83) | (4.70) | (4.62) | (4.09) | (4.00) | |
Female | −0.094 | −0.066 | −0.034 | − 0.040 | |
(−1.43) | (−1.00) | (− 0.52) | (0.60) | ||
Married | −0.125 | −0.168* | − 0.146* | −0.143* | |
(−1.69) | (−2.31) | (−2.05) | (−2.01) | ||
Higher education | 0.040 | 0.073 | 0.054 | 0.072 | |
(0.63) | (1.20) | (0.90) | (1.18) | ||
Age at survey | −0.005 | −0.004 | −0.005 | −0.004 | |
(−1.63) | (−1.36) | (−1.82) | (−1.15) | ||
Body Mass Index | −0.005 | −0.004 | − 0.006 | ||
(−0.71) | (−0.57) | (− 0.91) | |||
Heart disease | 0.076 | 0.095 | 0.063 | ||
(0.66) | (0.83) | (0.55) | |||
Second cancer | −0.444*** | −0.410*** | −0.474*** | ||
(−4.34) | (−4.09) | (−4.54) | |||
Relapse | 0.104 | 0.078 | 0.138 | ||
(1.30) | (0.98) | (1.65) | |||
Chronic fatigue | −0.126* | −0.109 | |||
(−1.93) | (−1.65) | ||||
Anxiety | −0.176* | −0.192* | |||
(−2.20) | (2.40) | ||||
Treatment lines | |||||
One | (base outcome) | ||||
Two | 0.009 | ||||
(0.13) | |||||
More than two | −0.168 | ||||
(−1.57) | |||||
Lymphoma type | |||||
Hodgkin | (base outcome) | ||||
Aggressive | −0.008 | ||||
(0.09) | |||||
Indolent | −0.143 | ||||
(−1.12) | |||||
Variation in model explained (%) | 0.11 | 0.15 | 0.23 | 0.28 | 0.30 |